| | | |  | | | | By Angus Chen Adobe Two teams of scientists identify a possible saboteur in the mix of immune cells that were engineered to help. Read More | | By Jayne Williamson-Lee Adobe Researchers are testing AI as a way to better predict when biopsies for suspected breast cancer are needed. Read More | | By Angus Chen Courtesy Lian Narunsky-Haziza and Nancy Gavert New research shows many fingerprints of fungi, but are they opportunistic bystanders, or accomplices to cancer? Read More | | Sponsor content by Amgen Oncology The power of precision: targeted therapies could transform prognoses for more cancer patients Small cell lung, gastric and gastroesophageal cancers are complex, aggressive diseases, and several factors impact why patients face a poor prognosis. At Amgen, scientists are advancing ambitious research into different investigational medicines targeting the DLL3 and FGFR2b proteins. Their goal is to bring precision medicine to more patients fighting some of the toughest-to-treat cancers. To learn more, read this story. | | By Brittany Trang Adobe The Biden administration's embrace of open access raises key issues not only for scholarly publishing but also for science itself. Read More | | By Adam Feuerstein Ryan Pierse/Getty Images There's plenty to watch in biotech in the months ahead, including results on an RNA-based drug and detailed data on an Alzheimer's therapy. Read More | |
No comments